Remarkable advances in next-generation sequencing technology enable the wide usage of sequencing as a clinical tool. Here, we conducted a large-scale prospective clinical sequencing program using the
As genomic analysis technology has advanced, it has become possible to sub-classify intrahepatic cholangiocarcinoma (ICC) at the histological or molecular level. However, there are no truly representa
Breast cancer is frequently diagnosed in women. While many sequencing studies have revealed frequently mutated genes in this disease, the relevance of some of these mutations are unclear. Because MAP3